{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:23:20Z","timestamp":1784211800107,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560271 and 81860296"],"award-info":[{"award-number":["81560271 and 81860296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"crossref","award":["2017GXNSFDA198005 and 2018GXNSFAA281038"],"award-info":[{"award-number":["2017GXNSFDA198005 and 2018GXNSFAA281038"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research of Guangxi Colleges and Universities","award":["KY2015ZD092"],"award-info":[{"award-number":["KY2015ZD092"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1548-y","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T13:32:15Z","timestamp":1567776735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17\/Treg balance"],"prefix":"10.1186","volume":"20","author":[{"given":"Dongdong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soulixay","family":"Senouthai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-5317","authenticated-orcid":false,"given":"Yanwu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"issue":"4","key":"1548_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MAJ.0b013e31827f4ee3","volume":"346","author":"N Maroz","year":"2013","unstructured":"Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319\u201323.","journal-title":"Am J Med Sci"},{"issue":"4","key":"1548_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00296-010-1771-0","volume":"32","author":"Q Xing","year":"2012","unstructured":"Xing Q, Wang B, Su H, Cui J, Li J. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int. 2012;32(4):949\u201358.","journal-title":"Rheumatol Int"},{"key":"1548_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10067-013-2237-z","volume":"32","author":"M Zhu","year":"2013","unstructured":"Zhu M, Mo H, Li D, Luo X, Zhang L. Th17\/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE). Clin Rheumatol. 2013;32:1045\u201352.","journal-title":"Clin Rheumatol"},{"key":"1548_CR4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","volume":"9","author":"T Katsuyama","year":"2018","unstructured":"Katsuyama T, Tsokos GC, Moulton VR. Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front Immunol. 2018;9:1088.","journal-title":"Front Immunol"},{"issue":"11","key":"1548_CR5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","volume":"36","author":"EC Freitas","year":"2017","unstructured":"Freitas EC, de Oliveira MS, Monticielo OA. Pristane-induced lupus: considerations on this experimental model. Clin Rheumatol. 2017;36(11):2403\u201314.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1548_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF02977694","volume":"30","author":"BS Chae","year":"2007","unstructured":"Chae BS, Shin TY. Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice. Arch Pharm Res. 2007;30(2):191\u20138.","journal-title":"Arch Pharm Res"},{"issue":"1","key":"1548_CR7","doi-asserted-by":"publisher","first-page":"G16","DOI":"10.1152\/ajpgi.00081.2017","volume":"313","author":"D Jayawardena","year":"2017","unstructured":"Jayawardena D, Guzman G, Gill RK, Alrefai WA, Onyuksel H, Dudeja PK. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. Am J Physiol Gastrointest Liver Physiol. 2017;313(1):G16\u201325.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"1548_CR8","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1177\/1535370215587533","volume":"240","author":"I Kasacka","year":"2015","unstructured":"Kasacka I, Piotrowska \u017b, Janiuk I. Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats. Exp Biol Med. 2015;240(11):1402\u20137.","journal-title":"Exp Biol Med"},{"issue":"1","key":"1548_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/01616412.2016.1250458","volume":"39","author":"G Deng","year":"2017","unstructured":"Deng G, Jin L. The effects of vasoactive intestinal peptide in neurodegenerative disorders. Neurol Res. 2017;39(1):65\u201372.","journal-title":"Neurol Res"},{"issue":"11","key":"1548_CR10","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.4049\/jimmunol.1800122","volume":"200","author":"R Benitez","year":"2018","unstructured":"Benitez R, Delgado-Maroto V, Caro M, Forte-Lago I, Duran-Prado M, O'Valle F, Lichtman AH, Gonzalez-Rey E, Delgado M. Vasoactive intestinal peptide ameliorates acute myocarditis and atherosclerosis by regulating inflammatory and autoimmune responses. J Immunol. 2018;200(11):3697\u2013710.","journal-title":"J Immunol"},{"issue":"undefined","key":"1548_CR11","first-page":"6043710","volume":"2018","author":"R Villanueva-Romero","year":"2018","unstructured":"Villanueva-Romero R, Guti\u00e9rrez-Ca\u00f1as I, Carri\u00f3n M, P\u00e9rez-Garc\u00eda S, Seoane IV, Mart\u00ednez C, Gomariz RP, Juarranz Y. The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of th subsets in rheumatoid arthritis. J Immunol Res. 2018;2018(undefined):6043710.","journal-title":"J Immunol Res"},{"issue":"6","key":"1548_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000486859","volume":"24","author":"C Li","year":"2018","unstructured":"Li C, Zhu F, Wu B, Wang Y. Vasoactive intestinal peptide protects salivary glands against structural injury and secretory dysfunction via IL-17A and AQP5 regulation in a model of Sj\u00f6gren syndrome. Neuroimmunomodulation. 2018;24(6):300\u20139.","journal-title":"Neuroimmunomodulation"},{"issue":"7","key":"1548_CR13","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.4049\/jimmunol.0900400","volume":"183","author":"D Pozo","year":"2009","unstructured":"Pozo D, Anderson P, Gonzalez-Rey E. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. J Immunol. 2009;183(7):4346\u201359.","journal-title":"J Immunol"},{"issue":"1","key":"1548_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-014-0514-0","volume":"17","author":"S Han","year":"2015","unstructured":"Han S, Zhuang H, Yuan X, Lee P, Yi L, Wilson JC, Vidal O, Hong SC, Yu S, Yang LJ. Maintenance of autoantibody production in pristane-induced murine lupus. Arthritis Res Ther. 2015;17(1):1\u201313.","journal-title":"Arthritis Res Ther"},{"key":"1548_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12882-015-0145-y","volume":"16","author":"Y You","year":"2015","unstructured":"You Y, Qin Y, Lin X, Yang F, Li J, Sooranna SR, Pinhu L. Methylprednisolone attenuates lipopolysaccharide-induced fractalkine expression in kidney of lupus-prone MRL\/lpr mice through the NF-kappaB pathway. BMC Nephrol. 2015;16:148.","journal-title":"BMC Nephrol"},{"issue":"10","key":"1548_CR16","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","volume":"8","author":"JA Bluestone","year":"2008","unstructured":"Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2008;8(10):2086\u201396.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"6","key":"1548_CR17","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","volume":"180","author":"M Satoh","year":"1994","unstructured":"Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristane. J Exp Med. 1994;180(6):2341\u20136.","journal-title":"J Exp Med"},{"issue":"16","key":"1548_CR18","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16):1526\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"1548_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","volume":"16","author":"JC Crisp\u00edn","year":"2010","unstructured":"Crisp\u00edn JC, Liossis SN, Kistoth K, Lieberman LA, Kyttaris VC, Juang YT, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med. 2010;16(2):47\u201357.","journal-title":"Trends Mol Med"},{"issue":"5","key":"1548_CR20","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24499","volume":"60","author":"J Yang","year":"2009","unstructured":"Yang J, Chu Y, Yang X, Gao D, Zhu L, Yang X, Wan L, Li M. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009;60(5):1472\u201383.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1548_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00726-011-1184-8","volume":"45","author":"M Delgado","year":"2013","unstructured":"Delgado M, Ganea D. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids. 2013;45(1):25\u201339.","journal-title":"Amino Acids"},{"issue":"47","key":"1548_CR22","doi-asserted-by":"publisher","first-page":"81873","DOI":"10.18632\/oncotarget.20704","volume":"8","author":"P Forghani","year":"2017","unstructured":"Forghani P, Petersen CT, Waller EK. Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity. Oncotarget. 2017;8(47):81873\u20139.","journal-title":"Oncotarget"},{"issue":"undefined","key":"1548_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.prostaglandins.2016.03.001","volume":"123","author":"H Shi","year":"2016","unstructured":"Shi H, Carion TW, Jiang Y, Steinle JJ, Berger EA. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-\u03b1 and enhances RvD1. Prostaglandins Other Lipid Mediat. 2016;123(undefined):28\u201332.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"7","key":"1548_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/icb.2010.29","volume":"88","author":"RP Gomariz","year":"2010","unstructured":"Gomariz RP, Guti\u00e9rrez-Ca\u00f1as I, Mart\u00ednez C, Juarranz Y, Leceta J. New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes. Immunol Cell Biol. 2010;88(7):734\u201345.","journal-title":"Immunol Cell Biol"},{"issue":"undefined","key":"1548_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbi.2014.09.020","volume":"44","author":"YV Tan","year":"2015","unstructured":"Tan YV, Abad C, Wang Y, Lopez R, Waschek J. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1\/Th17 and reduced Th2\/Treg responses. Brain Behav Immun. 2015;44(undefined):167\u201375.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1548_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2174\/187153012803832611","volume":"12","author":"H Ibrahim","year":"2012","unstructured":"Ibrahim H, Barrow P, Foster N. VIP as a potential therapeutic agent in gram negative sepsis. Endocr Metab Immune Disord Drug Targets. 2012;12(4):308\u201315.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11","key":"1548_CR27","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1021\/acs.molpharmaceut.7b00452","volume":"14","author":"D Jayawardena","year":"2017","unstructured":"Jayawardena D, Anbazhagan AN, Guzman G, Dudeja PK, Onyuksel H. Vasoactive intestinal peptide nanomedicine for the management of inflammatory bowel disease. Mol Pharm. 2017;14(11):3698\u2013708.","journal-title":"Mol Pharm"},{"issue":"3","key":"1548_CR28","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/art.21652","volume":"54","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum. 2006;54(3):864\u201376.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1548_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cellimm.2010.07.010","volume":"265","author":"S Deng","year":"2010","unstructured":"Deng S, Xi Y, Wang H, Hao J, Niu X, Li W, Tao Y, Chen G. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis. Cell Immunol. 2010;265(2):105\u201310.","journal-title":"Cell Immunol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1548-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1548-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1548-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:11:24Z","timestamp":1599174684000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1548-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1548-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"14 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments that included housing and using the mice were reviewed and approved by the Animal Experiments Committee of Youjiang Medical University for Nationalities (No. 2017060501), and were performed in accordance with the guidelines for the care and use of laboratory animals established by the Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}